Exome sequencing improves genetic diagnosis of fetal increased nuchal translucency
Authors:
- 15 July 2020
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 40 (11) , 1426-1431
Abstract
Objective: The aim of this retrospective study is to determine the monogenic syndromes in fetuses with isolated first‐trimester increased nuchal translucency (NT) in order to provide more accurate parental counseling.Methods: Medical trio exome sequencing (ES) was performed on DNA extracted from chorionic villi in 73 fetuses with isolated first‐trimester increased NT (≥3.5 mm) and normal chromosomal microarray analysis (CMA). This testing targets coding exons for 4200 clinically relevant disease‐causing genes. The interpretation of variants was performed according to the American College of Medical Genetics guidelines.Results: Pathogenic variants were detected in four cases in which phenotypes and genotypes correlate well. Medical trio ES offered a 5.5% (4/73) increase in diagnostic rate over CMA in cases with isolated increased NT. Three of four cases with pathogenic variants developed structural anomalies on ultrasound at mid pregnancy, leading to the pregnancy termination. Only one case with a pathogenic variant demonstrated normal ultrasound throughout pregnancy.Conclusion: Our results indicate that after a normal CMA, fetuses with isolated first‐trimester increased NT have a 1.4% (1/73) risk of significant childhood genetic syndromes caused by known disease‐causing variants, which will not be detectable on prenatal ultrasound. This information may be useful in parental counseling.Keywords
Funding Information
- National Natural Science Foundation of China (81873836)
This publication has 24 references indexed in Scilit:
- Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta‐analysisUltrasound in Obstetrics & Gynecology, 2015
- Brief Report: SETD2 Mutation in a Child with Autism, Intellectual Disabilities and EpilepsyJournal of Autism and Developmental Disorders, 2015
- Why increased nuchal translucency is associated with congenital heart disease: a systematic review on genetic mechanismsPrenatal Diagnosis, 2015
- Risk of critical congenital heart defects by nuchal translucency normsAmerican Journal of Obstetrics and Gynecology, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta‐analysisUltrasound in Obstetrics & Gynecology, 2013
- Molecular and clinical analysis ofRAF1in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activationHuman Mutation, 2010
- Relation Between Increased Fetal Nuchal Translucency Thickness and Chromosomal DefectsObstetrics & Gynecology, 2006
- PTPN11 Mutations in Noonan Syndrome: Molecular Spectrum, Genotype-Phenotype Correlation, and Phenotypic HeterogeneityThe American Journal of Human Genetics, 2002
- Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotypeUltrasound in Obstetrics & Gynecology, 2001